CDLX - Company ID 0001666071
The table below shows Cardlytics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $233.27M | $278.30M | $309.20M | $298.54M | $267.12M | $186.89M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $39.77M | $49.61M | $51.35M | $54.44M | $38.10M | $17.53M |
| SG&A |
Cardlytics, Inc. reported annual revenue of $233.27M for fiscal year 2025. That is down 16.2% from $278.30M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $112.82M (FY 2016) to $233.27M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $47.27M |
| $56.48M |
| $58.81M |
| $81.45M |
| $66.22M |
| $46.53M |
| Operating income | -$101.82M | -$195.50M | -$135.67M | -$457.78M | -$122.60M | -$53.92M |
| Income tax | $0.00 | $0.00 | $0.00 | -$1.45M | -$7.86M | $0.00 |
| Net income | -$104.00M | -$189.00M | -$135.00M | -$465.26M | -$128.56M | -$55.42M |
| EPS (diluted) | -$1.95 | -$3.91 | -$3.69 | -$13.92 | - | - |